2022-07-26-CBInsights-2022年2季度数字健康状况报告（英）_197页_4mb

Digital Health Market Overview Q2 2022:

Global digital health funding fell 32% QoQ to $7.1B, with a record low for exits and a notable shift in investor focus. Europe was the sole market showing funding growth (+6%), while the US and Asia saw significant declines. Health IT emerged as a bright spot, with a 27% YoY increase in funding. Mega-rounds and deal sizes declined across most regions, reflecting cautious investor behavior post-pandemic.

Regional Disparities:

• Europe was the outlier, with $1.1B raised.
• Silicon Valley funding dropped 57% YoY to $3.5B, while Boston showed strong resilience.
• China/Asia experienced slowed growth despite early-stage strength.

Sector Highlights:

• Health IT saw robust funding (+27% YoY), with $1.1B raised.
• Europe led in digital therapeutics, with unicorn births significantly higher than other regions.
• Deal concentration increased, with M&A and SPACs declining, signaling a buyer’s market for established players.

Investor Shifts:

• General Catalyst, Insight Partners, and Eight Roads Ventures dominated Q2 deals.
• Valuations stabilized in Series D+ rounds, with a median decline of 32% YoY.

Key Takeaways:

• Diversify geographically, focusing on Europe and emerging sub-sectors like health IT.
• Monitor valuation trends to identify undervalued opportunities.
• Strengthen partnerships to reduce reliance on high-risk funding rounds.

Recommendation:
Focus on markets with growth potential and sectors benefiting from value-based care, such as health IT and digital therapeutics.